The Wearable Gap: Why Sensors Are Outrunning the Trials That Use Them
Wearables are generating physiological data at a scale clinical trials have never seen before. But a March 2026 review...
Real-World Evidence
The FDA Doesn’t Have a GLP-1 Problem. It Has an Evidence Problem.
A trial emulation study of 174,678 type 1 diabetes patients shows GLP-1RAs cut major cardiovascular events and end-stage kidney...
How a Single eGFR Change Is Exposing the Clinical Trial Industry’s Embedded Patient Bias Problem
A new real-world evidence study shows that removing race from the kidney function algorithm resulted in 5.3 more transplants...